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S U M M A R Y
Background: There is limited information regarding the prevalence of hepatitis B in Lao PDR, where the
hepatitis disease burden is substantial. Thus, reliable seroprevalence data is needed for the disease,
based on probability sampling.
Methods: A stratiﬁed, multistage, cluster sampling survey of hepatitis B surface antigen (HBsAg)
positivity among children aged 5–9 years and their mothers aged 15–45 years was conducted.
Participants were selected randomly from the central region of Lao PDR via probability-proportional-to-
size sampling. Blood samples were collected onto ﬁlter paper and subsequently analyzed using a
chemiluminescent microparticle immunoassay.
Results: A total of 911 mother-and-child pairs were collected; the seroprevalence of HBsAg was
estimated to be 2.1% (95% conﬁdence interval 0.8–3.4%) among children and 4.1% (95% conﬁdence
interval 2.6–5.5%) in their mothers after taking into account the sampling design and the weight of each
sample. The children’s HBsAg positivity was positively associated with maternal infection and being
born in a non-health facility, while the maternal infection status was not associated with any
background characteristic.
Conclusions: Lao PDR has a relatively lower HBsAg prevalence in the general population compared to
surrounding countries. To ensure comparability to other countries and to future data, rapid ﬁeld tests are
recommended for a nationwide prevalence survey.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
According to the World Health Organization (WHO) estimate,
approximately 360 million people worldwide have a chronic
hepatitis B virus (HBV) infection,1,2 and almost half of these
individuals live in the Western Paciﬁc Region, which comprises
only approximately 28% of the global population.3 Every year, an
estimated 620 000 people die from HBV-related diseases,1 and over
90% of them had acquired the virus decades earlier at birth or* Corresponding author. Tel.: +81-3-3202-7181 (ext. 2722); fax: +81-3-3205-7860.
E-mail address: m-hachiya@it.ncgm.go.jp (M. Hachiya).
http://dx.doi.org/10.1016/j.ijid.2015.04.020
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).during early childhood.4,5 In 1992, the WHO recommended that
childhood hepatitis B vaccination be included in the immunization
programs of all countries.6 The Regional Committee for the WHO
Western Paciﬁc Region adopted this recommendation in 2005,
calling for a reduction in chronic hepatitis B infection to less than
2% among 5-year-old children as an interim milestone towards the
ﬁnal regional goal of less than 1% by 2012.7 To achieve this goal, it
was recommended that the birth dose coverage be improved to
65% and the third dose of hepatitis B vaccination coverage be
improved to 85%.8
Hepatitis B surface antigen (HBsAg) is a serological marker of
hepatitis B infection and can be detected during the acute and
chronic phases of the disease. Therefore, HBsAg seroprevalenceciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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population, and a serological survey of this marker is recom-
mended to measure the impact of immunization policies.2
Lao People’s Democratic Republic (Lao PDR) is a landlocked
country located in the centre of the Indochina Peninsula. Since 90% of
the land is covered by mountains with deep forest and 80% of the
total population lives in rural areas, health services are difﬁcult to
provide in Lao PDR. In addition, because the country is bordered by
hepatitis B hyperendemic countries such as Cambodia,9 China,10
Myanmar,10,11 Thailand,12 and Vietnam,13 Lao PDR has been
considered an endemic country.14,15 The country initiated its
expanded program on immunization (EPI) in selected regions in
1984, and the program became available nationwide in the mid-
1990s. According to a report from the Ministry of Health, Lao PDR,
immunization coverage for bacille Calmette–Gue´rin (BCG), the third
oral polio vaccine, the third diphtheria, pertussis, tetanus, hepatitis B
vaccine, and the ﬁrst measles vaccine was 60%, 46%, 45%, and 36%,
respectively, in 2004. Hepatitis B vaccination was included in the EPI
in 2002. Hepatitis B vaccination for newborns was integrated into
the EPI starting in 2004; this gradually expanded from central
hospitals to rural areas. There have been no previous reports on the
infection rates of chronic HBV in the general population. Therefore,
population-based seroprevalence surveys for hepatitis B are
warranted to better estimate the current prevalence of hepatitis B
and to evaluate the impact of immunization policies that focus on
preventing mother-to-child transmission.2,8
There is limited information regarding the prevalence of hepatitis
B in Lao PDR, indicating the need for a population-based household
survey to provide a reliable seroprevalence for the disease. However,
the sparsely distributed population, less developed infrastructure,
and limited human and ﬁnancial resources in Lao PDR make the
conducting of surveys difﬁcult. Filter paper blood collection is simple
and inexpensive, and the storage and transport methods are easy.
HBsAg testing with dried blood spots (DBS) is suitable for large-scale
surveys in resource-limited countries.16,17
The Ministry of Health in Lao PDR plans to conduct a nationwide
hepatitis B prevalence survey in the near future. Therefore, it was
proposed that a household survey be conducted, as a pilot survey,
in the central region of the country, where the infrastructure and
transportation are relatively better than in the rest of the country.
The primary objectives of this survey were to: (1) assess the
operational and programmatic feasibility of a population-based
sero-epidemiological survey, and (2) estimate chronic hepatitis B
infection rates, as determined from the HBsAg seroprevalence
among children and their mothers.
2. Materials and methods
The ﬁeld work for the survey was carried out at the end of
January 2011 and lasted for 10 days. The study used a multistage,
stratiﬁed, random cluster sampling design. The sample was
restricted to children aged 5 to 9 years, and their mothers aged
15 to 45 years on January 1, 2011. The children had to be
biologically related to their mothers and not adopted. The rationale
for the target age group of children used in this survey was based
on the fact that the risk of acquiring chronic HBV infection is
highest in the ﬁrst 5 years of life,4,15 as observed in the
neighbouring hyperendemic countries.
2.1. Sample size
The sample size was calculated based on the expected HBsAg
seroprevalence rate of 15% among children and their mothers. The
sample size of 960 was calculated at a 5% level of signiﬁcance with
a precision of 3.5%. The design effect for cluster sampling was
assumed to be 2.0 with a response rate of 85%.2.2. Sampling
Four provinces and the Vientiane Municipality in the central
region of Lao PDR, which account for 2.5 million people (approxi-
mately 40% of the total population), were selected for the study. The
population of Vientiane Municipality is 691 721, of Borikhamxay
Province is 225 301, of Khammuane Province is 337 390, of Vientiane
Province is 388 895, and of Savannakhet Province is 825 902. There
are nine districts in Vientiane Municipality, six in Borikhamxay
Province, nine in Khammuane Province, 13 in Vientiane Province,
and 15 in Savannakhet Province.
Provinces were considered as strata, yielding a total of ﬁve
strata. In the ﬁrst stage of sampling, four districts were selected
randomly from each stratum using probability-proportional-to-
size (PPS) based on the population data from the 2005 census
conducted in Lao PDR. In the second stage, two villages were
selected randomly from each selected district by PPS, and a total of
40 villages, as clusters, were selected. Twenty survey teams were
formed, and each team comprised a supervisor and two surveyors,
nominated from the district health staff. If surveyors could not
reach the designated village due to obstacles such as ﬂoods or
mudslides, the nearest village on the way back to the district centre
from the designated village could be selected as an alternative. In
each selected village, surveyors developed a list of households that
had children aged from 5 to 9 years based on the data from the
poverty reduction program, EPI, or other relevant residential lists.
From these lists, 24 households were selected randomly via a
lottery, and the youngest child within the eligible age range and
his/her mother were sampled for the survey. Adopted children
were excluded from the lists.
2.3. Questionnaires
A brief face-to-face questionnaire was administered to the
sampled mothers. Information was collected on the demographic
status and history of the child (i.e., age, sex, place of birth, and
immunization history), as well as the socioeconomic status of the
child’s household, as measured by the maternal educational
background and occupation of the household head. Additionally,
questions regarding exposure to potential risk factors for acquiring
hepatitis B infection (e.g., surgery, blood transfusion, and sharing
toothbrushes) and history of past hepatitis infection among other
family members were asked.
2.4. Testing for HBsAg
Capillary blood was collected onto Whatman 903 ﬁlter paper
protein saver (Whatman, Maidstone, Kent, UK) via a ﬁnger prick and
air-dried for at least 60 min; ﬁlter papers were kept in sealed plastic
bags and transported to Japan. DBSs were stored at ambient
temperature in Lao PDR for 7 to 10 days after sample collection, and
thereafter at 4 8C for 3 months prior to being tested at the
Hepatology Research Centre, National Centre for Global Health
and Medicine. Blood samples were extracted from DBSs by punching
two bloodstained circles 3 mm in diameter and eluting overnight in
500 ml of phosphate-buffered saline (pH 7.2). Eluates were tested for
HBsAg using a chemiluminescent microparticle immunoassay
(Architect i2000SR; Abbott Diagnostics, IL, USA). The relative light
unit (RLU) value of each sample was detected with an automated
system. The sample was considered to be positive for HBsAg based
on comparisons to the RLU value of a calibration sample.
2.5. Consent, conﬁdentiality, ethical considerations, and safety issues
The surveyors explained the detailed survey objectives and
procedures to the local authorities and selected mothers and
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obtained from the parents or legal representatives if mothers were
illiterate. Informed consent, questionnaires, and the blood collection
process were supervised by provincial- and national-level super-
visors. The survey proposal was reviewed and approved by the ethics
committees of the Ministry of Health, Lao PDR, and the National
Centre for Global Health and Medicine, Japan (NCGM-950).
2.6. Data entry and analysis
All of the completed questionnaires were taken to a centralized
location, and to reduce any data entry-related errors, the double
data entry method was performed in a Microsoft Excel worksheet
(Microsoft Ofﬁce 2007) along with validation and correction.
STATA 12 (Stata Corp., College Station, TX, USA) was used for the
data analysis. Calculations of the overall prevalence among
children and mothers took into account the individual weight of
each sample. The Poisson exact method for rare events was used to
calculate the 95% conﬁdence interval (CI) of HBsAg prevalence for
each region. Chi-square and Fisher’s exact tests were used to
examine the relationships between the independent variables and
HBsAg positivity in the bivariate analysis. Multiple logistic
regression models were used to investigate the independent
predictors of different households and individual characteristicsTable 1
Prevalence of HBsAg among children and mothers in the central region of Lao PDR by 
Children (5–9 years old) 
n (%) HBsAg-positive % 
Mother’s age, years (n = 911)
15–20 9 (0.99) 0 0.00%
21–25 97 (10.65) 1 1.03%
26–30 274 (30.08) 8 2.92%
31–35 266 (29.20) 6 2.26%
36–40 177 (19.43) 4 2.26%
41–45 88 (9.66) 2 2.27%
Mother’s ethnicity (n = 911)
Lowland Lao 783 (85.95) 19 2.43%
Highland Lao 83 (9.11) 1 1.20%
Hmong 5 (0.55) 1 20.00%
Unknown 40 (4.39) 0 0.00%
Main transportation to the nearest health facility (n = 906)
On foot 78 (8.61) 1 1.28%
Bicycle 23 (2.54) 1 4.35%
Motor bike 554 (61.15) 15 2.71%
Car 120 (13.25) 2 1.67%
Hand tractor 120 (13.25) 1 0.83%
Other 11 (1.21) 1 9.09%
Time to nearest health facility (n = 876)
10 min 174 (19.86) 8 4.60%
>10 to 30 min 386 (44.06) 4 1.04%
>30 to 60 min 162 (18.49) 5 3.09%
>60 min 154 (17.58) 4 2.60%
Mother’s education level (n = 911)
No education 178 (19.54) 2 1.12%
Primary school 404 (44.35) 14 3.47%
Junior high school 201 (22.06) 4 1.99%
High school 113 (12.40) 1 0.88%
College 13 (1.43) 0 0.00%
Other or unknown 2 (0.22) 0 0.00%
Occupation of household head (n = 911)
Farmer 589 (64.65) 13 2.21%
Fisherman 4 (0.44) 0 0.00%
Labourer 118 (12.95) 4 3.39%
Public ofﬁcer 112 (12.29) 1 0.89%
Factory employee 8 (0.88) 0 0.00%
General employee 19 (2.09) 0 0.00%
Merchant 54 (5.93) 3 5.56%
Other 7 (0.77) 0 0.00%
Family history of liver diseases except mother (n = 911)
Yes 95 (10.43) 1 1.05%
No 816 (89.57) 20 2.45%
HBsAg, hepatitis B surface antigen; CI, conﬁdence interval.for HBsAg positivity. All estimates and standard errors were
adjusted for the multistage clustered sampling design to ensure
representative and unbiased results. A p-value of <0.05 was
considered statistically signiﬁcant.
3. Results
Forty villages from 20 districts in central Lao PDR were selected
for the study. The survey teams successfully visited all of the
40 selected villages and conducted the questionnaire and serosur-
vey. Of the 960 selected mother-and-child pairs, 49 were not eligible
for analysis and were excluded from the study (35 pairs did not meet
the study age requirement for the child (e.g., 3–4 years old or
unknown), 13 pairs did not meet the study age requirement for the
mother (e.g., >45 years old or unknown), and one pair did not have a
blood sample from the child (reason unknown)). Thus, a total of
911 mother-and-child pairs were included in this analysis.
The baseline characteristics of the selected mothers and their
children are summarized in Table 1. The mean age of the mothers
was 32.4 years (95% CI 32.0–32.8 years), and the mean age of the
children was 6.7 years (95% CI 6.7–6.8 years). Of the children
sampled, 453 (49.7%) were male and 458 (50.3%) were female. One
hundred and seventy-one children out of 911 had written
immunization records at the survey. Among these, immunizationselected background characteristics
Mothers (15–45 years old)
95% CI HBsAg-positive % 95% CI
 0 0.00%
 (0.00–3.01) 5 5.15% (0.68–9.63)
 (0.91–4.93) 13 4.74% (2.22–7.28)
 (0.46–4.05) 14 5.26% (2.56–7.96)
 (0.05–4.47) 6 3.39% (0.70–6.08)
 (0.00–5.45) 2 2.27% (0.00–5.45)
 (1.35–3.51) 36 4.60% (3.13–6.07)
 (0.00–3.60) 3 3.61% (0.00–7.71)
 (0.00–75.53) 0 0.00%
 1 2.50% (0.00–7.56)
 (0.00–3.83) 5 6.41% (0.85–11.97)
 (0.00–13.36) 0 0.00%
 (1.35–4.06) 21 3.79% (2.20–5.39)
 (0.00–3.99) 8 6.67% (2.14–11.19)
 (0.00–2.48) 4 3.33% (0.08–6.59)
 (0.00–29.35) 2 18.18% (0.00–45.36)
 (1.45–7.74) 10 5.75% (2.25–9.24)
 (0.02–2.05) 17 4.40% (2.35–6.46)
 (0.39–5.78) 8 4.94% (1.57–8.31)
 (0.06–5.14) 5 3.25% (0.42–6.08)
 (0.00–2.69) 5 2.81% (0.36–5.26)
 (1.67–5.26) 18 4.46% (2.43–6.48)
 (0.04–3.94) 10 4.98% (1.94–8.01)
 (0.00–2.64) 6 5.31% (1.11–9.51)
 1 7.69% (0.00–24.45)
 0 0.00%
 (1.02–3.40) 19 3.23% (1.79–4.66)
 0 0.00%
 (0.08–6.70) 6 5.08% (1.06–9.11)
 (0.00–2.66) 7 6.25% (1.70–10.80)
 0 0.00%
 2 10.53% (0.00–25.72)
 (0.00–11.87) 6 11.11% (2.45–19.77)
 0 0.00%
 (0.00–3.14) 4 4.21% (0.98–8.32)
 (1.39–3.51) 36 4.41% (3.00–5.82)
Table 2
HBsAg prevalence among children and their mothers by province
Children (5–9 years
old)
n = 911
Mothers (15–45 years
old)
n = 911
Vientiane Municipality 2.15% (0.05–4.25) 3.76% (1.00–6.52)
(n = 186) 4 7
Vientiane Province 2.75% (0.35–5.14) 6.59% (2.95–10.23)
(n = 182) 5 12
Borikhamxay Province 3.91% (1.04–6.78) 5.59% (2.19–8.98)
(n = 179) 7 10
Khammuane Province 1.11% (0.00–2.66) 2.78% (0.35–5.20)
(n = 180) 2 5
Savannakhet Province 1.63% (0.00–3.48) 3.26% (0.67–5.85)
(n = 184) 3 6
Total 2.09% (0.79–3.38) 4.06% (2.58–5.54)
(n = 911) 21 40
HBsAg, hepatitis B surface antigen.
Table 4
Adjusted odds ratio for being HBsAg-positive among mothers aged 15 to 45 years in
the central region of Lao PDR by selected background characteristics
Characteristics (Reference group) Adjusted OR 95% CI p-Value
Address (Khammuane)
Vientiane Capital 1.03 (0.21–4.91) 0.973
Vientiane Province 2.12 (0.42–10.63) 0.338
Borikhamxay 1.82 (0.38–8.67) 0.426
Savannakhet 1.23 (0.28–5.41) 0.763
Age (15–30 years)
30–45 years 0.86 (0.45–1.65) 0.633
Mother’s education level (None)
Finished primary school or upper 1.35 (0.25–7.43) 0.709
Occupation of household head (Other)
Labourer 1.44 (0.41–5.06) 0.538
Family history of liver diseases except mother herself (None)
Yes or unknown 0.73 (0.14–3.82) 0.689
Time to nearest health facility (10 min)
<10 min 1.35 (0.59–3.05) 0.450
History of surgery (Never)
Yes or unknown 2.11 (0.83–5.41) 0.111
HBsAg, hepatitis B surface antigen; OR, odds ratio; CI, conﬁdence interval.
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for the third diphtheria, pertussis, tetanus, hepatitis B vaccine was
87%, and for the ﬁrst measles vaccine was 80%.
Of the 911 pairs included in the study, 21 children and
40 mothers were positive for HBsAg. Eleven out of 21 HBsAg-
positive children (52.3%) had HBsAg-positive mothers, whereas the
other 10 were from non-infected mothers. The prevalence was
calculated as 2.1% (95% CI 0.8–3.4%) in children and 4.1% (95% CI
2.6–5.5%) in their mothers after taking into account the sampling
design and the weight of each sample (Table 2). HBsAg prevalence
varied by province, but the differences among provinces were not
statistically signiﬁcant for either children or mothers. In calculat-
ing HBsAg prevalence, the design effects were determined to be
1.6 for children and 1.1 for mothers (Table 2).
To determine whether background characteristics affect HBsAg
status, a logistic regression analysis was conducted. For the
children, maternal HBsAg positivity and being born in a non-health
facility were positively associated with hepatitis B infection
(Table 3), whereas the other potential risk factors were not. ForTable 3
Adjusted odds ratio for being HBsAg-positive among children aged 5 to 9 years in
the central region of Lao PDR by selected background characteristics
Characteristics (Reference group) Adjusted OR 95% CI p-Value
Address (Khammuane)
Vientiane Capital 1.06 (0.23–5.00) 0.934
Vientiane Province 0.94 (0.11–7.88) 0.949
Borikhamxay 1.64 (0.31–8.76) 0.537
Savannakhet 0.88 (0.07–10.63) 0.916
Mother’s HBsAg status (Negative)
Positive 31.31 (12.23–80.16) 0.000a
Mother’s age (15–30 years)
31–45 years 0.87 (0.10–7.50) 0.894
Mother’s education level (None)
Finished primary school or upper 2.83 (0.33–24.49) 0.319
Occupation of household head (Other)
Labourer 2.14 (0.60–7.65) 0.222
Family history of liver diseases except mother’s (None)
Yes or unknown 0.98 (0.05–18.70) 0.987
Time to nearest health facility (10 min)
<10 min 1.89 (0.70–5.09) 0.193
Sex (Female)
Male 1.92 (0.67–5.47) 0.207
Birth place (Health facility)
Non-health facility 3.01 (1.06–8.72) 0.039a
History of HepB vaccination at birth (None or unknown)
Received 2.58 (0.31–21.71) 0.357
History of HepB vaccination (Never or less than twice)
Received 3 times 0.48 (0.12–1.92) 0.279
Sharing tooth brush (Never)
Yes or unknown 1.25 (0.36–4.33) 0.706
HBsAg, hepatitis B surface antigen; OR, odds ratio; CI, conﬁdence interval.
a p < 0.05.the mothers, no background characteristic was associated with
HBsAg positivity (Table 4).
To evaluate the potential risk factors for children acquiring a
chronic hepatitis B infection without vertical transmission, logistic
regression analysis was conducted for children born from HBsAg-
negative mothers (n = 871). A history of regular hepatitis B
vaccination (scheduled at 6, 10, and 14 weeks after birth) was
negatively associated with the children’s HBsAg status (p = 0.04),
while immunization after the delivery (within 24 h) was not. Other
risk factors, including birth place, did not show any signiﬁcant
association with HBsAg status among children (Table 5).
4. Discussion
To the best of our knowledge, this is the ﬁrst population-based,
cross-sectional survey to estimate chronic hepatitis B prevalence
among the general population in Lao PDR. The major ﬁndings
were: (1) the questionnaire and serosurvey using multistage,Table 5
Adjusted odds ratio for being HBsAg-positive among children aged 5 to 9 years born
to HBsAg-negative mothers in the central region of Lao PDR by selected background
characteristics
Characteristics (reference group) Adjusted
OR
95% CI p-Value
Mother’s age (15–30 years)
31–45 years 1.36 (0.37–6.05) 0.665
Mother’s education level (None)
Finished primary school or upper 3.93 (0.45–33.11) 0.212
Occupation of household head (Other)
Farmer 3.96 (0.65–23.01) 0.133
Family history of liver diseases (None)
Yes or unknown 1.17 (0.11–7.74) 0.887
Time to nearest health facility (10 min)
<10 min 3.00 (0.64–13.78) 0.160
Sex (Female)
Male 3.97 (0.80–19.12) 0.088
Birth place (Health facility)
Non-health facility 1.38 (0.29–6.58) 0.683
History of HepB vaccination at birth (Not received or unknown)
Received 2.89 (0.50–15.72) 0.226
History of regular HepB vaccination (2 times or unknown)
3 times 0.11 (0.13–0.93) 0.042a
Sharing tooth brush (Never)
Yes or unknown 2.04 (0.37–10.68) 0.404
HBsAg, hepatitis B surface antigen; OR, odds ratio; CI, conﬁdence interval.
a p < 0.05.
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the central region of Lao PDR; (2) the estimated prevalence in the
general population was 2.1% in children and 4.1% in women of
childbearing age; and (3) HBsAg positivity in mothers was
positively associated with HBsAg positivity in their children,
whereas no condition was signiﬁcantly associated with HBsAg
positivity in mothers.
4.1. Feasibility of the household survey
Multistage, stratiﬁed, random cluster sampling is the most
reliable strategy for accurately estimating the prevalence of health
status and conditions among the general population within a
deﬁned geographical area under constraints of limited time and
resources.18 However, in Lao PDR, this sampling strategy has rarely
been applied for these purposes. For example, EPI coverage,19
measles immunization coverage,20 antenatal care,21 energy
malnutrition,22 and smoking23 have been assessed via convenience
sampling rather than random sampling methods. The exact
reasons for not using a probability sampling methodology are
not clear. One exception is the Lao Reproductive Health Survey
2005, which focused on population and development planning.24
The Lao Reproductive Health Survey 2005 used a two-stage,
stratiﬁed cluster sampling method for the household survey and
reported standard errors and design effects for each value
measured.
The present survey was conducted successfully in terms of
operational and programmatic feasibility, because the data
collection was completed within 10 days with response rates of
100%, and the calculated design effects were 1.1 to 1.6 for HBsAg
prevalence. This sampling methodology can be applied for other
purposes as well.
4.2. HBsAg seroprevalence among children and their mothers
There have been no previous reports on the prevalence of
hepatitis B in the general population of Lao PDR. The prevalence of
chronic hepatitis B, as determined by HBsAg, has been reported
previously in blood donors25 and hospitalized patients.26 However,
this selection of individuals may result in biased ﬁndings, as they
may not be representative of the general population. For example,
HBsAg prevalence among blood donors may be higher than that in
the general population when donors are paid and lower when they
are unpaid.27
The surrounding Southeast Asian countries have previously
been considered as highly endemic areas for hepatitis B. For
instance, data from Cambodia,9 China,10 Myanmar,10,11 Thailand,12
and Vietnam13 suggest a prevalence of 8–10%. The results of the
present study revealed a lower prevalence than expected. There
are a few reasons to explain this ﬁnding. First, the central part of
Lao PDR is different from other regions (e.g., better health services
and cultural differences). Second, the sensitivity of HBsAg testing
on blood collected on Whatman 903 ﬁlter paper in the ﬁeld setting
may be low. Lastly, the high temperature and humidity may have
damaged the HBsAg protein prior to analysis.
4.3. Risk factors for acquiring hepatitis B
The present study revealed the mother’s HBsAg status and
child’s place of birth to be signiﬁcantly associated with the child’s
infection status (Table 3). Other risk factors, such as male child,9
ethnicity,13 family history of liver diseases,9 and the place of
residence9,13 were found not to be associated. This may be the
result of the limited sample size.
The HBsAg positivity results for the children and their mothers
indicated that transmission was horizontal in almost half of thehepatitis-infected children. A potential risk factor for this was the
number of routine hepatitis B vaccinations (2 times; Table 5).
This is important, especially in a country such as Lao PDR, where
the rate of delivery by a skilled birth attendant is less than 30%. The
WHO emphasizes that hepatitis B immunization should be given
during the ﬁrst 24 h after delivery; however, a ﬁrst vaccination
even at >24 h may greatly contribute to the prevention of hepatitis
B infection from horizontal sources. Moreover, the importance of
regular immunization during infancy cannot be overemphasized.
4.4. Study limitations
There are several limitations that need to be discussed. First, the
survey design, which applied PPS, was based on population data
from the latest national census in 2005. Since 2005, the population
of the country has increased from 6 200 000 to 6 600 000, and the
number of districts has increased (separated) from 141 to
143. During the same period, the number of villages has decreased
(merged). However, no updated population data have been made
available since 2005. Therefore, the present study may have under-
or over-estimated the population in selected villages. Moreover,
the hepatitis B immunization policy has expanded over the last
10 years, and therefore our sampled children may have, in part,
represented the pre-vaccine era.
Another limitation of this study is that the seroprevalence
survey was conducted using Whatman 903 ﬁlter paper. HBsAg is
heat-stable and resistant to drying,28,29 and DBSs are convenient
and relatively cheap, thus DBSs have been used previously for
seroprevalence surveys on hepatitis B.17,30,31 However, the
sensitivity and speciﬁcity of ﬁeld samples are still not well
documented. Therefore, DBS ﬁeld test results should be compared
to other methods like ELISA and rapid tests in the future.
Additionally, seroprevalence surveys should be repeated over
time, along with hepatitis B control measures, and the methodol-
ogy should ideally be comparable to that used in neighbouring
countries and areas. Given the comparability of the results, the use
of a widely available rapid ﬁeld test, such as the Alere Determine
HBsAg test card (Alere Medical Co., Ltd, Chiba, Japan),9 is
recommended for nationwide surveys. The sensitivity and
speciﬁcity of the Determine rapid test have been reported as
97–100% and 100% from ﬁeld studies in Vietnam32 and China,33
thus the rapid test is recommended by the WHO.34
4.5. Conclusions
In the present study, an HBsAg prevalence survey targeting
children and their mothers was conducted successfully in the
central part of Lao PDR. The prevalence was estimated to be 2.1%
(95% CI 0.8–3.4%) for children aged 5 to 9 years, and 4.1% (95% CI
2.6–5.5%) for mothers aged 15 to 45 years, after taking into account
the sampling design and the weight of each sample. The prevalence
of hepatitis B in Lao PDR was found to be lower than that in other
Southeast Asian countries, as well as the prevalence reported in
previous studies conducted in Lao PDR. Given the comparability of
the ﬁndings, the use of an HBsAg rapid test is strongly
recommended for future nationwide surveys.
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